Logo image of OCGN

OCUGEN INC (OCGN) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:OCGN - US67577C1053 - Common Stock

1.23 USD
+0.02 (+1.65%)
Last: 12/10/2025, 8:09:58 PM
1.2301 USD
+0 (+0.01%)
After Hours: 12/10/2025, 8:09:58 PM
Fundamental Rating

1

OCGN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 531 industry peers in the Biotechnology industry. OCGN may be in some trouble as it scores bad on both profitability and health. OCGN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

OCGN had negative earnings in the past year.
OCGN had a negative operating cash flow in the past year.
OCGN had negative earnings in each of the past 5 years.
In the past 5 years OCGN always reported negative operating cash flow.
OCGN Yearly Net Income VS EBIT VS OCF VS FCFOCGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

OCGN has a Return On Assets of -111.15%. This is in the lower half of the industry: OCGN underperforms 78.91% of its industry peers.
The Return On Equity of OCGN (-1812.06%) is worse than 82.86% of its industry peers.
Industry RankSector Rank
ROA -111.15%
ROE -1812.06%
ROIC N/A
ROA(3y)-79.4%
ROA(5y)-83.76%
ROE(3y)-144.88%
ROE(5y)-130.94%
ROIC(3y)N/A
ROIC(5y)N/A
OCGN Yearly ROA, ROE, ROICOCGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

OCGN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OCGN Yearly Profit, Operating, Gross MarginsOCGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20K -40K -60K -80K

More info and screens

1

2. Health

2.1 Basic Checks

OCGN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OCGN has more shares outstanding
The number of shares outstanding for OCGN has been increased compared to 5 years ago.
The debt/assets ratio for OCGN is higher compared to a year ago.
OCGN Yearly Shares OutstandingOCGN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
OCGN Yearly Total Debt VS Total AssetsOCGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

OCGN has an Altman-Z score of -8.27. This is a bad value and indicates that OCGN is not financially healthy and even has some risk of bankruptcy.
OCGN has a worse Altman-Z score (-8.27) than 70.43% of its industry peers.
OCGN has a Debt/Equity ratio of 8.04. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of OCGN (8.04) is worse than 82.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 8.04
Debt/FCF N/A
Altman-Z -8.27
ROIC/WACCN/A
WACC8.63%
OCGN Yearly LT Debt VS Equity VS FCFOCGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

2.3 Liquidity

OCGN has a Current Ratio of 1.85. This is a normal value and indicates that OCGN is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.85, OCGN is not doing good in the industry: 78.72% of the companies in the same industry are doing better.
A Quick Ratio of 1.85 indicates that OCGN should not have too much problems paying its short term obligations.
The Quick ratio of OCGN (1.85) is worse than 76.65% of its industry peers.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.85
OCGN Yearly Current Assets VS Current LiabilitesOCGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for OCGN have decreased strongly by -29.41% in the last year.
The Revenue for OCGN has decreased by -48.07% in the past year. This is quite bad
EPS 1Y (TTM)-29.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40%
Revenue 1Y (TTM)-48.07%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%54.23%

3.2 Future

OCGN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 45.45% yearly.
The Revenue is expected to grow by 209.51% on average over the next years. This is a very strong growth
EPS Next Y-20.25%
EPS Next 2Y-15.38%
EPS Next 3Y21.92%
EPS Next 5Y45.45%
Revenue Next Year45.38%
Revenue Next 2Y-23.84%
Revenue Next 3Y230.39%
Revenue Next 5Y209.51%

3.3 Evolution

OCGN Yearly Revenue VS EstimatesOCGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
OCGN Yearly EPS VS EstimatesOCGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -50 -100 -150

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OCGN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OCGN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OCGN Price Earnings VS Forward Price EarningsOCGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OCGN Per share dataOCGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1 -0.15 -0.2 -0.25

4.3 Compensation for Growth

OCGN's earnings are expected to grow with 21.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-15.38%
EPS Next 3Y21.92%

More info and screens

0

5. Dividend

5.1 Amount

OCGN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OCUGEN INC

NASDAQ:OCGN (12/10/2025, 8:09:58 PM)

After market: 1.2301 +0 (+0.01%)

1.23

+0.02 (+1.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)03-03 2026-03-03/amc
Inst Owners14.92%
Inst Owner Change-14.85%
Ins Owners1.12%
Ins Owner Change0%
Market Cap384.15M
Revenue(TTM)5.37M
Net Income(TTM)-64.02M
Analysts81.82
Price Target9.18 (646.34%)
Short Float %19.21%
Short Ratio11.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.9%
Min EPS beat(2)-22.55%
Max EPS beat(2)14.75%
EPS beat(4)3
Avg EPS beat(4)3.39%
Min EPS beat(4)-22.55%
Max EPS beat(4)14.75%
EPS beat(8)7
Avg EPS beat(8)15.68%
EPS beat(12)9
Avg EPS beat(12)14.24%
EPS beat(16)10
Avg EPS beat(16)-204.99%
Revenue beat(2)2
Avg Revenue beat(2)248.45%
Min Revenue beat(2)212.3%
Max Revenue beat(2)284.59%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.76%
PT rev (3m)38.46%
EPS NQ rev (1m)-3.45%
EPS NQ rev (3m)0%
EPS NY rev (1m)-6.67%
EPS NY rev (3m)1.18%
Revenue NQ rev (1m)-16.14%
Revenue NQ rev (3m)98.46%
Revenue NY rev (1m)39.53%
Revenue NY rev (3m)39.09%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 71.54
P/FCF N/A
P/OCF N/A
P/B 108.73
P/tB 108.73
EV/EBITDA N/A
EPS(TTM)-0.22
EYN/A
EPS(NY)-0.25
Fwd EYN/A
FCF(TTM)-0.17
FCFYN/A
OCF(TTM)-0.17
OCFYN/A
SpS0.02
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -111.15%
ROE -1812.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-79.4%
ROA(5y)-83.76%
ROE(3y)-144.88%
ROE(5y)-130.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 8.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4.82%
Cap/Sales 3.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 1.85
Altman-Z -8.27
F-Score1
WACC8.63%
ROIC/WACCN/A
Cap/Depr(3y)863.08%
Cap/Depr(5y)672.89%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40%
EPS Next Y-20.25%
EPS Next 2Y-15.38%
EPS Next 3Y21.92%
EPS Next 5Y45.45%
Revenue 1Y (TTM)-48.07%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%54.23%
Revenue Next Year45.38%
Revenue Next 2Y-23.84%
Revenue Next 3Y230.39%
Revenue Next 5Y209.51%
EBIT growth 1Y3.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y30.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.12%
OCF growth 3YN/A
OCF growth 5YN/A

OCUGEN INC / OCGN FAQ

What is the fundamental rating for OCGN stock?

ChartMill assigns a fundamental rating of 1 / 10 to OCGN.


What is the valuation status of OCUGEN INC (OCGN) stock?

ChartMill assigns a valuation rating of 1 / 10 to OCUGEN INC (OCGN). This can be considered as Overvalued.


What is the profitability of OCGN stock?

OCUGEN INC (OCGN) has a profitability rating of 0 / 10.


Can you provide the financial health for OCGN stock?

The financial health rating of OCUGEN INC (OCGN) is 1 / 10.


Can you provide the expected EPS growth for OCGN stock?

The Earnings per Share (EPS) of OCUGEN INC (OCGN) is expected to decline by -20.25% in the next year.